title: The use of ipilimumab in patients with rheumatoid arthritis and metastatic melanoma.
authors: Department of Cancer Medicine, Peter MacCallum Cancer Centre, East Melbourne; Systems Biology & Personalized Medicine Division, Walter & Eliza Hall Institute of Medical Research (WEHI), Melbourne; Department of Medicine, University of Melbourne, Melbourne, Australia.
authors: B
authors: B
authors: Lee
authors: Department of Cancer Medicine, Peter MacCallum Cancer Centre, East Melbourne.
authors: A
authors: A
authors: Wong
authors: Department of Cancer Medicine, Peter MacCallum Cancer Centre, East Melbourne.
authors: D
authors: D
authors: Kee
authors: Cancer Immunology Research Laboratory, Peter MacCallum Cancer Centre, East Melbourne; Department of Pathology, University of Melbourne, Parkville.
authors: P
authors: P
authors: Neeson
authors: Department of Cancer Medicine, Peter MacCallum Cancer Centre, East Melbourne; Cancer Development and Treatment Laboratory, Peter MacCallum Cancer Centre, Melbourne; Department of Pathology, University of Melbourne, Parkville.
authors: M
authors: M
authors: Shackleton
authors: Department of Cancer Medicine, Peter MacCallum Cancer Centre, East Melbourne; Molecular Oncology Laboratory, Oncogenic Signalling and Growth Control Program; Translational Research Laboratory, Cancer Therapeutics Program, Peter MacCallum Cancer Centre, East Melbourne; Department of Pathology, University of Melbourne, Parkville; Department of Medicine, University of Melbourne, Melbourne, Australia.
authors: G
authors: G
authors: McArthur
authors: Department of Cancer Medicine, Peter MacCallum Cancer Centre, East Melbourne; Translational Research Laboratory, Cancer Therapeutics Program, Peter MacCallum Cancer Centre, East Melbourne; Department of Medicine, University of Melbourne, Melbourne, Australia. Electronic address: shahneen.sandhu@petermac.org.
authors: S
authors: S
authors: Sandhu
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D000074322:Antineoplastic Agents, Immunological / Q000494:pharmacology / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000150:complications / Q000000981:diagnostic imaging / Q000188:drug therapy*; D060908:CTLA-4 Antigen / Q000037:antagonists & inhibitors; D005260:Female; D006801:Humans; D000074324:Ipilimumab / Q000494:pharmacology / Q000627:therapeutic use*; D008297:Male; D008545:Melanoma / Q000150:complications / Q000000981:diagnostic imaging / Q000188:drug therapy*; D008875:Middle Aged; D012189:Retrospective Studies; D012878:Skin Neoplasms / Q000150:complications / Q000000981:diagnostic imaging / Q000188:drug therapy*
chemical_list: D000074322:Antineoplastic Agents, Immunological; D060908:CTLA-4 Antigen; C556706:CTLA4 protein, human; D000074324:Ipilimumab